4.7 Article

Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-kappa B pathway

Journal

PHYTOTHERAPY RESEARCH
Volume 22, Issue 3, Pages 407-415

Publisher

WILEY
DOI: 10.1002/ptr.2340

Keywords

Shikonin; oral squamous cell carcinoma (OSCC); growth inhibition; apoptosis; NF-kappa B; caspase family

Ask authors/readers for more resources

Shikonin, a naphthoquinone pigment isolated from the Chinese herbal therapeutic, Zicao, has been shown to exhibit antioxidant and anticancer effects. In this study, its ability to induce apoptosis in cultured Tca-8113 oral cancer cells was studied. Treatment of the Tca-8113 cells with a variety of concentrations of Shikonin (1040 gm) resulted in dose- and time-dependent sequences of events marked by apoptosis, as shown by the loss of cell viability, chromatin condensation, internucleosomal DNA fragmentation and sub-G1 phase accumulation. Furthermore, apoptosis in the Tca-8113 cells was accompanied by the activation of protease caspase-8, -9, -3 and low expression of Bcl-2 protein. Interestingly, inactivation of the NF-kappa B pathway was found in shikonin-induced apoptosis in Tca-8113 cells. These results raise the possibility that the anti-tumor effects of Shikonin in Tca-8113 cells are at least partly through the inactivation of the NF-kappa B pathway and subsequent activation of protease caspase family. Pharmacological inhibition of the NF-kappa B activity by Shikonin might be a powerful treatment option for OSCC in which activation of NF-kappa B plays a critical role in tumor growth and progression. Copyright (C) 2007 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available